ELECTRO vet S13

ELECTROvet™ S13 was engineered for veterinary Electrochemotherapy (ECT) and Electrogenetherapy (EGT) treatments applied on cutaneous and subcutaneous tumor nodules, specifically in horses, cats and dogs.

Optimal parameters of electrical pulses (e.g. number, duration, voltage and repetition frequency) are set according to the chosen protocol, ECT or EGT. For user and patient safety, these parameters cannot be adjusted.

References:

Cemazar M, Tamzali Y, Sersa G, Tozon N, Mir LM, Miklavcic D, Lowe R, Teissie J. Electrochemotherapy in veterinary oncology. J Vet Intern Med. 2008 Jul-Aug;22(4):826-31.

Tamzali Y, Borde L, Rols MP, Golzio M, Lyazrhi F, Teissie J. Successful treatment of equine sarcoids with cisplatinelectrochemotherapy: A retrospective study of 48 cases. Equine Vet J. 2012 March; 44(2) :214-220

Teissié J, Escoffre JM, Paganin A, Chabot S, Bellard E, Wasungu L, Rols MP, Golzio M.Drug delivery by electropulsation: Recent developments in oncology. Int J Pharm. 2012 Feb ;423(1) :3-6

ELECTROvet™ S13 is a veterinary device for electrochemotherapy treatment of solid tumors.

ELECTROCHEMOTHERAPY is a new method in the treatment of cancer. It combines the administration of an anticancer drug and electrical field pulses at the site of the tumor. By increasing the permeability of the cell membrane, a targeted injection of the cytotoxic molecule ensures a precise, efficient eradication of tumors.